Acquisition

Bristol Myers to Acquire RayzeBio in a $4.1 Bn Deal December 28, 2023 This acquisition seeks to establish Bristol’s presence in one of the most promising and fastest-growing new modalities for the treatment of patients with solid tumours, delivering radioactive payloads to cancer cells in a targeted manner.

Sterling Accuris Diagnostics Expands Portfolio with Acquisition of Vaibhav Analytical Services December 14, 2023 The acquisition, as shared by Rajiv Sharma, MD of Sterling Accuris Diagnostics in an official statement, aims to broaden the scope of services, particularly in pharmaceutical analytical testing.

AbbVie to Acquire Cerevel Therapeutics for $8.7 Bn to Boost Neurological Drug Portfolio December 11, 2023 Trading in options for Cerevel experienced an unusual surge in the days leading up to the announcement, with significant interest in upside call options.

Syngene Acquires Biologics Manufacturing Facility from Stelis Biopharma December 4, 2023 The acquisition, known as 'Unit 3,' was finalised at a revised gross value of INR 617 Cr, following adjustments from the initially stated INR 702 Cr.

Eris Lifesciences Acquires Biocon Biologics' Nephro & Dermatology Units for INR 366 Cr November 10, 2023 The acquisition includes working capital and a team of over 120 professionals from Biocon Biologics' nephro and derma units, who will join Eris following the deal.

Norwest Venture Partners Acquires 40% Stake in Regency Healthcare for INR 600 Cr November 8, 2023 The objective of this acquisition is to further strengthen Regency Healthcare's position in the healthcare sector, particularly in Kanpur and the surrounding regions.

Jhunjhunwala Family-Backed IKS Health Acquires US-Based AQuity Solutions for  INR 1,600 Cr November 1, 2023 The acquisition valued at $200 million (about INR 1,600 Cr) was financed partially through a INR 1,000 Cr loan from three major banks and the rest from internal funds.

Zydus Lifesciences Acquires LiqMeds to Enhance Oral Liquid Product Line November 1, 2023 Zydus Lifesciences Limited, a pharmaceutical company based in Ahmedabad, has acquired UK-based LiqMeds Group of companies.

Bristol Myers Squibb Acquires Mirati Therapeutics for $4.8 Billion October 10, 2023 US pharmaceutical giant Bristol Myers Squibb has acquired Mirati Therapeutics, a clinical-stage biotechnology company focussed on targeted oncology treatments, for $4.8 billion.

American Thoma Bravo is in Agreement to Acquire EHR Major NextGen Healthcare in $23.95 Per Share Deal September 8, 2023 Under the terms of the deal, Thoma Bravo will acquire NextGen for $23.95 per share, representing a substantial 46% premium over NextGen's closing price on August 22. The acquisition is anticipated to be finalised in the fourth quarter of this year.

Cipla to Acquire South African OTC Pharma Leader Actor Pharma September 5, 2023 Cipla South Africa, a subsidiary of Ace Mumbai-based pharmaceutical company Cipla, has officially signed a binding term sheet to acquire Actor Pharma, a prominent player in the over-the-counter (OTC) and generic medicine sector.

Biocon Subsidiary Acquires Eywa Pharma Inc.'s US Manufacturing Facility for $7.7 Mn September 5, 2023 This strategic move comes at a total consideration of $7.7 Mn and is set to reinforce Biocon's presence in the US pharmaceutical market.